Bacoba AG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of BAP5191 in Healthy Adults Following Topical Application of Repeat Doses (NCT05848453) | Bacoba AG | 2023-03-28 |
Track Bacoba AG automatically
Every clearance here is in the API, with alerts when new ones post.